Chen W, Schoen F J, Levy R J
Division of Pediatric Cardiology, University of Michigan Medical Center, Ann Arbor 48109-0576.
Circulation. 1994 Jul;90(1):323-9. doi: 10.1161/01.cir.90.1.323.
Calcification is a frequent cause of the clinical failures of glutaraldehyde-pretreated bioprosthetic heart valves (BPHV) fabricated from glutaraldehyde-cross-linked porcine aortic valves. 2-Amino oleic acid (AOA) has been shown in previous in vivo studies to be a promising anticalcification agent. Our objective was to investigate the mechanism of calcification inhibition mediated by AOA pretreatment of porcine aortic valve bioprostheses.
BPHV tissues were treated with an AOA solution for 72 hours before experimentation. The diffusion of AOA across both cusp and aortic wall was evaluated. The lag time for AOA to diffuse across the aortic wall was prolonged compared with that of the cusp. An extraction study was performed to determine the stability of AOA binding; the results indicated that the binding was relatively stable regardless of solvent extraction conditions. The interaction between ionic calcium and AOA on treated tissue also was investigated by evaluating the patterns of calcium diffusion across both treated and untreated tissues. The results showed that AOA significantly reduced the diffusion of calcium. AOA inhibition of aortic valve calcification (calcium level, 5.5 +/- 3.0 mg/g of tissue compared with control; calcium level, 91.2 +/- 19.5 mg/g of tissue) but not aortic wall (calcium level, 158.7 +/- 10.3 mg/g of tissue compared with control; calcium level, 157.5 +/- 7.9 mg/g of tissue) was demonstrated on representative specimens from valves implanted in left ventricular apicoaortic shunts explanted after 150 days.
AOA covalently binds to glutaraldehyde-pretreated bioprosthetic heart valve tissue, presumably as the result of an aldehyde-amino reaction. Covalently bound AOA diminishes Ca2+ diffusion compared with non-AOA-pretreated bioprosthetic tissues. This may explain in part the anticalcification mechanism of AOA. Furthermore, AOA inhibits calcification of porcine BPHV cusps in the circulation.
钙化是由戊二醛交联猪主动脉瓣制成的戊二醛预处理生物人工心脏瓣膜(BPHV)临床失效的常见原因。先前的体内研究表明,2-氨基油酸(AOA)是一种很有前景的抗钙化剂。我们的目的是研究AOA预处理猪主动脉瓣生物假体介导的钙化抑制机制。
在实验前,将BPHV组织用AOA溶液处理72小时。评估了AOA在瓣叶和主动脉壁中的扩散情况。与瓣叶相比,AOA扩散穿过主动脉壁的滞后时间延长。进行了一项提取研究以确定AOA结合的稳定性;结果表明,无论溶剂提取条件如何,结合都相对稳定。通过评估钙在处理过的和未处理的组织中的扩散模式,还研究了离子钙与AOA在处理过的组织上的相互作用。结果表明,AOA显著降低了钙的扩散。在植入左心室尖主动脉分流器150天后取出的瓣膜的代表性标本上,证实了AOA对主动脉瓣钙化的抑制作用(钙水平,与对照组相比为5.5±3.0mg/g组织;钙水平,对照组为91.2±19.5mg/g组织),但对主动脉壁没有抑制作用(钙水平,与对照组相比为158.7±10.3mg/g组织;钙水平,对照组为157.5±7.9mg/g组织)。
AOA与戊二醛预处理的生物人工心脏瓣膜组织共价结合,推测是醛-氨基反应的结果。与未用AOA预处理的生物假体组织相比,共价结合的AOA减少了Ca2+扩散。这可能部分解释了AOA的抗钙化机制。此外,AOA抑制了循环中猪BPHV瓣叶的钙化。